About Technology Issues FAQ

Links

Phase I Trial Using Proteasome Inhibitor Bortezomib and Concurrent Temozolomide and Radiotherapy for Central Nervous System Malignancies

Phase I Trial Using Proteasome Inhibitor Bortezomib and Concurrent Temozolomide and Radiotherapy for Central Nervous System Malignancies — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.